Our Story



The preparation and execution of the event was highly professional, and it was an excellent environment to facilitate networking and collaborations. The choice for location and venue were superb. Looking forward to participating in such events in the future.

Clinical Instructor, Jonsson Comprehensive Cancer Center, UCLA

Introducing the World Vaccine & Immunotherapy Congress


After an incredibly successful inaugural year, the World Vaccine and Immunotherapy Congress is back in 2018 to bring you more content, learning and business development opportunities so you can take advantage of the rich biotech and funding environment that the West Coast offers.

Whilst still focussing on the vaccine and immunotherapy industry the scope of the event has expanded considerably and will delve deeper into topics surrounding vaccine development, cancer immunotherapy, funding and partnerships as well as exploring new topics in clinical trials & development, bioprocessing, manufacture and delivery, and the development and use of antibodies for both infectious diseases and cancer. 

This is the congress for top decision makers of the vaccine and immunotherapy industry with both scientific and commercial interests, specifically interested in both learning and/or partnering.

No matter where your interest lies we have content, networking and potential partners for you.


What to expect?


Providing attendees one stop progressive scientific and strategic solutions to the vaccine and immunotherapy industry, through executive level commentary, case studies and real-time analysis from key stakeholders to bring about faster, more cost-effective and more efficacious vaccines.

  • Meet the key players from the Human Vaccines Project - including all five universities and academics centers involved as well as senior members of the Scientific Steering Committee. 

  • Hear exciting new research from the directors some of the top cancer centers in the US as well as senior representatives from leading consortiums including the Parker Institute for Cancer Immunotherapy, AACR GENIE Project, the San Diego Center for Precision Immunotherapy and the Translational Genomics Research Institute (TGen). 

  • Explore the latest methods and technologies that allow better understanding of the immune system and improve vaccine development and other immunotherapy approaches against infectious diseases and cancer. This includes integrating synthetic biology, omics, immune profiling, bioinformatics, systems biology and new-generation adjuvants with break through immunotherapy immunomodulators like check point inhibitors and oncolytic viruses in combinational therapies. 

  • Hear from C-Level executives from all the key vaccine developers and thought leaders from pharma, biotech’s, academics and government, in a combined scientific and commercial environment where CRO’s, CMO’s, EQM’s, Biotech’s and platform technology organisations can demonstrate their latest products and services and do business. 

  • Listen to updates on the latest discovery-stage infectious and non-infectious vaccines and hear clinical phase I, II and III data from leading biotech’s, big pharma and regulatory experts. 

  • Discover new technology for the manufacture, delivery and administration of vaccines , considerations for the manufacture of novel immunotherapies and engineered antibody formats. 





2018 Advisory Board



Alex Sette

  Dr Biol. Sci. Alessandro Sette

Center Head, Division Head, and Professor Center for Infectious Disease

La Jolla Institute

Steven Reed

Dr Steven Reed

Founder, President, and CSO

Infectious Disease Research Institute (IDRI)


Peter Hortez

Dr Peter Hotez MD PhD

Dean of the National School of Tropical Medicine

Baylor College of Medicine

Karin Joss

Dr Karin Jooss

Executive Vice President of Research, and Chief Scientific Officer

Gritstone Oncology


Jerald Sadoff

Dr Jerald Sadoff

Senior Advisor

Janssen Infectious Diseases and Vaccines 


Bali Pulendran

Prof Bali Pulendran

Professor in the Department of Pathology and Laboratory Medicine

Emory University School of Medicine


Roy Baynes

Dr Roy Baynes

Senior Vice President, Global Clinical Development and Chief Medical Officer


Wayne Koff

Dr. Wayne C. Koff

President and CEO, The Human Vaccines Project

International Aids Vaccine Initiative Inc


Wayne Koff

Dr Maria Karasarides

Executive Director, ImmunoOncology

Regeneron Pharmaceuticals

Wayne Koff

Dr Ezra Cohen

Professor of Medicine, UC San Diego Moores Cancer Center and Co-Director

San Diego Center for Precision Immunotherapy




Get involved

To exhibit, sponsor or speak at the event contact
Oliver Breed on +44 (0)20 7092 1156
or oliver.breed@terrapinn.com

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156


To speak:
Lauren Sheppard
+44 (0)207 092 1211